`
`Us 8,673,927 K1
`(10) Number:
`United States Patent
`
`
`Dugi et al. Feb. 14, 2018 (45) Certificate Issued:
`
`(54) USES OF DPP-IV INHIBITORS
`
`(75)
`
`Inventors: Klaus Dugi; Frank Himmelsbach;
`Michael Mark
`
`(73) Assignee: Boehringer Ingelheim International
`GmbH
`
`Trial Number:
`
`IPR2016-01563 filed Aug. 10, 2016
`
`Inter Partes Review Certificate for:
`
`Patent No.: 8,673,927
`Issued:
`Mar. 18, 2014
`Appl. N0.:
`12/946,193
`Filed:
`Nov. 15, 2010
`
`The results of IPR2016-01563 are reflected in this inter
`
`partes review certificate under 35 U.S.C. 318(b).
`
`
`
`INTER PARTES REVIEW CERTIFICATE
`
`U.S. Patent 8,673,927 K1
`Trial No. IPR2016-01563
`
`Certificate Issued Feb. 14, 2018
`
`1
`
`AS A RESULT OF THE INTER PARTES
`REVIEW PROCEEDING, IT HAS BEEN
`DETERMINED THAT:
`
`Claims 1 and 10 are cancelled.
`*
`>X<
`*
`>X<
`
`*
`
`